Skip to main content
. 2022 Jul 22;27(15):4681. doi: 10.3390/molecules27154681

Figure 3.

Figure 3

Two potent and selective c-Met inhibitors containing the 1,2,3-triazolo[4,5-b]pyrazine core: PF-04217903 and Savolitinib.